Fulgent Genetics (FLGT) Assets Average (2016 - 2026)

Fulgent Genetics has disclosed Assets Average across 11 years of filings, most recently posting $1.2 billion for Q1 2026.

• Assets Average for Q1 2026 came in at $1.2 billion, down 2.3% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 billion (down 2.3% YoY), and the FY2025 annual result was $1.2 billion, down 0.89% from the prior year.
• Assets Average came in at $1.2 billion for Q1 2026 at Fulgent Genetics, down from $1.2 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $1.5 billion in Q2 2022 to a low of $735.0 million in Q1 2023.
• The 5-year median for Assets Average is $1.2 billion (2024), against an average of $1.2 billion.
• Peak annual rise in Assets Average reached 73.03% in 2023, while the deepest fall reached 46.43% in 2023.
• Fulgent Genetics' Assets Average stood at $749.5 million in 2022, then jumped by 73.03% to $1.3 billion in 2023, then retreated by 5.4% to $1.2 billion in 2024, then fell by 1.04% to $1.2 billion in 2025, then dropped by 2.4% to $1.2 billion in 2026.
• The last three Assets Average figures came in at $1.2 billion (Q1 2026), $1.2 billion (Q4 2025), and $1.2 billion (Q3 2025), per Business Quant data.